To the Editor Recent research on mental stress–induced myocardial ischemia (MSIMI) has been devoted to pathophysiology, prognosis, and intervention, the latter being the focus of the Responses of Mental Stress Induced Myocardial Ischemia to Escitalopram Treatment (REMIT) trial.1 Aside from the early work of Deanfield et al,2 researchers have mostly used secondary markers of ischemia (eg, left ventricular [LV] dysfunction) rather than directly assessing myocardial blood flow. The REMIT trial also used secondary indices (wall motion and LV dysfunction), which is unfortunate because more recent research has shown these to lack the sensitivity and specificity of single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) for the assessment of ischemia provoked by mental stress.3
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.